Section three – Commissioning budget and finances

The vast majority of the DHSC budget is used to commission NHS services in England, whether at a national level by NHS England, or a local level by CCGs. In 2016/17, NHS England’s budget was £106.8bn – 88% of the total resource budget of the DHSC (RDEL). Of this, £77.9bn was provided to 209 CCGs for local commissioning – 73% of NHS England’s budget.

2016/17 saw the introduction of the Sustainability and Transformation Fund (STF), which provided £1.8bn directly from NHS England to NHS trusts rather than via CCGs (discussed in more detail in Chapter 5). Despite this, the proportion of NHS England’s budget provided to CCGs has risen slightly from 72% in 2015/16, due to a reduction of £2bn in direct commissioner spend from NHS England. This was partly driven by an increase in CCGs commissioning primary care.

This chapter looks first at the national combined commissioner budget, then focuses on the financial pressures facing local commissioners.

National commissioning

The total budget for NHS England rose by £2.4bn in 2016/17, from £104.4bn in 2015/16 to £106.8bn. This 2.3% increase was much greater than the 0.6% increase for the DHSC total budget. The vast majority of this increase was passed on to NHS trusts, via the STF (£1.8bn) or through the normal route of commissioning services (£1.2bn). This was partly offset by reductions in other areas (Figure 4).

Figure 4: Change in NHS England spending by sector, 2015/16–2016/17 (2017/18 prices)

Figure 4: Change in NHS England spending by sector, 2015/16–2016/17 (2017/18 prices)

Note: 2016/17 accounts for DHSC show that spending on GP services were broadly flat in real terms between 2015/16 and 2016/17.

Source: NHS England Annual Accounts 2016/17

An additional £200m was spent on services from non-NHS providers in 2016/17 – an increase of 1.5% from the previous year. This is much lower than the year-on-year increase of £934m in 2015/16. In recent years, growth in funding for non-NHS providers has previously increased at a faster rate than for NHS trusts, with the share of NHS England’s spending accounted for by non-NHS providers rising from 11.9% in 2014/15 to 12.5% in 2015/16. This share fell slightly to 12.4% in 2016/17.

Approximately 70% of spending by commissioners on non-NHS providers went to independent service providers (ISPs), consistent with previous years.

Spending on prescribing costs fell by £215m in 2016/17, while spending on primary care (general practice), ophthalmic services, pharmaceutical services and dental services fell by £646m. Of this latter figure, the largest fall was £485m for dental services, while spending on GP services was broadly flat, with an increase of 0.02%. Spending on GP services refers to spending by commissioners through general and primary medical services, which make up approximately 78% of total spending and investment in general practice in England. In total, spending and investment in general practice increased by £300m (3.0%) in 2016/17, with large increases in IT expenditure (£158m) and training paid for by HEE (£65m). Dental services spending refers to primary care dental spending. There is also additional spending on dental care in secondary and community care. Total spending on dental care fell from £3.8bn in 2015/16 to £3.7bn in 2016/17.

NHS England had a total surplus of £918m in 2016/17, including a surplus for CCGs of £153m (Figure 5). A significant portion of this underspend relates to a ‘risk reserve’, whereby 1% (£814m) of the total commissioners’ budget was held back in case of a provider-side deficit, to improve the overall financial position of commissioners and trusts at year-end. This funding had been planned to fund priorities in-year that would not require future spending (so called non-recurrent expenditure). At year end the commissioners had not spent the money in the reserve, so this balanced the provider sector deficit, which was larger than planned (see Chapter 4 for more detail on providers).

Figure 5: Surplus/deficit of CCGs and NHS England, 2013/14–2017/18 (2017/18 prices)

Figure 5: Surplus/deficit of CCGs and NHS England, 2013/14–2017/18 (2017/18 prices)

Note: 2017/18 forecast is at Q3 2017/18.

Source: NHS England Financial Performance Reports

Clinical commissioning groups and direct commissioning

The overall CCG surplus of £153m for 2016/17 is an improvement on 2015/16, when there was an overall deficit of £16m. However, a greater proportion of CCGs reported a deficit in 2016/17 – this rose to 29% from 15% in 2015/16 (see Figure 6). The increase reflects the divergence of the financial position of CCGs: some commissioners have been able to increase surpluses, while others have grown deficits. The National Audit Office (NAO) found this was due to large overspends among those with overspends, and large underspends among those with underspends.

The numbers in Figure 5 relate to the in-year financial performance of CCGs in 2016/17 – the spending of commissioners against plan. Another way to analyse the financial position of commissioners is to look at their cumulative position, by adding the in-year result to the cumulative position of previous years. In 2016/17, the cumulative surplus of all CCGs fell from £341m to £178m. As the NAO reported, this shows that CCGs are maximising their resources and drawing down on reserves where possible to continue to meet the funding needs of trusts.

NHS England (excluding CCGs) had a surplus of £765m in 2016/17 – larger than the previous two years. This included underspends of £302m in direct commissioning and £447m in administration and central programmes.

Pressures in 2017/18

The pressure on commissioners has continued in 2017/18. By Q3, NHS England was forecasting that it would end the year with an underspend of £18.5m – less than 0.01% of the budget. CCGs reported an overall deficit of £471m in Q3 2017/18, with an end of year forecast deficit of £291m.

Again, commissioners are holding a risk reserve, which is now set at 0.5% of CCG allocations. NHS England is holding £200m in a central reserve and providers are holding 0.5% of local clinical quality and innovation funds. NHS England has indicated that the risk reserve funding currently held by CCGs and NHS England is unlikely to be spent, to offset the position of the provider sector. In 2016/17, a similar situation meant that the forecast year-end deficit in Q3 of £377m was improved to an actual surplus of £153m, suggesting the final outturn for 2017/18 could be substantially improved.

Figure 6: Proportion of CCGs in deficit, 2013/14–2017/18

Figure 6: Proportion of CCGs in deficit, 2013/14–2017/18

Note: Numbers refer to in-year position of CCGs.

Source: NHS England Financial Performance Reports


††† Per correspondence with NHS England.

Previous Next